Graftys
Graftys is an innovation-driven Medtech company committed to the development and manufacturing of synthetic bone biomaterials. Graftys markets products covered by a large patent portfolio in more than 25 countries throughout the world, with regulatory approvals in Europe, the USA, Canada, North and South America and Australia.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2005
About Us
Graftys was incepted in 2005 by three business-driven executives of the orthopedic industry and an academic Research Director in the field of synthetic biomaterials, leading a renowned Research Unit in Nantes.
Graftys has implemented a hybrid business model combining a worldwide commercial activity and a strong R&D platform in liaison with the French Academic Research.
Graftys’ mission is to become a major player in the design, manufacturing and commercialization of synthetic bone biomaterials.
To achieve that goal, Graftys has developed an innovation-driven growing pipeline through partnerships with leading academic research institutions in Europe and has progressively built a portfolio aimed at addressing specific and unmet patients’ medical needs. Graftys commercializes its first generation of products in more than 25 countries, including the United States.